Cargando…
Updating dual-specificity tyrosine-phosphorylation-regulated kinase 2 (DYRK2): molecular basis, functions and role in diseases
Members of the dual-specificity tyrosine-regulated kinase (DYRKs) subfamily possess a distinctive capacity to phosphorylate tyrosine, serine, and threonine residues. Among the DYRK class II members, DYRK2 is considered a unique protein due to its role in disease. According to the post-transcriptiona...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658070/ https://www.ncbi.nlm.nih.gov/pubmed/32462403 http://dx.doi.org/10.1007/s00018-020-03556-1 |
_version_ | 1783608586848436224 |
---|---|
author | Correa-Sáez, Alejandro Jiménez-Izquierdo, Rafael Garrido-Rodríguez, Martín Morrugares, Rosario Muñoz, Eduardo Calzado, Marco A. |
author_facet | Correa-Sáez, Alejandro Jiménez-Izquierdo, Rafael Garrido-Rodríguez, Martín Morrugares, Rosario Muñoz, Eduardo Calzado, Marco A. |
author_sort | Correa-Sáez, Alejandro |
collection | PubMed |
description | Members of the dual-specificity tyrosine-regulated kinase (DYRKs) subfamily possess a distinctive capacity to phosphorylate tyrosine, serine, and threonine residues. Among the DYRK class II members, DYRK2 is considered a unique protein due to its role in disease. According to the post-transcriptional and post-translational modifications, DYRK2 expression greatly differs among human tissues. Regarding its mechanism of action, this kinase performs direct phosphorylation on its substrates or acts as a priming kinase, enabling subsequent substrate phosphorylation by GSK3β. Moreover, DYRK2 acts as a scaffold for the EDVP E3 ligase complex during the G2/M phase of cell cycle. DYRK2 functions such as cell survival, cell development, cell differentiation, proteasome regulation, and microtubules were studied in complete detail in this review. We have also gathered available information from different bioinformatic resources to show DYRK2 interactome, normal and tumoral tissue expression, and recurrent cancer mutations. Then, here we present an innovative approach to clarify DYRK2 functionality and importance. DYRK2 roles in diseases have been studied in detail, highlighting this kinase as a key protein in cancer development. First, DYRK2 regulation of c-Jun, c-Myc, Rpt3, TERT, and katanin p60 reveals the implication of this kinase in cell-cycle-mediated cancer development. Additionally, depletion of this kinase correlated with reduced apoptosis, with consequences on cancer patient response to chemotherapy. Other functions like cancer stem cell formation and epithelial–mesenchymal transition regulation are also controlled by DYRK2. Furthermore, the pharmacological modulation of this protein by different inhibitors (harmine, curcumine, LDN192960, and ID-8) has enabled to clarify DYRK2 functionality. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00018-020-03556-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7658070 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-76580702020-11-12 Updating dual-specificity tyrosine-phosphorylation-regulated kinase 2 (DYRK2): molecular basis, functions and role in diseases Correa-Sáez, Alejandro Jiménez-Izquierdo, Rafael Garrido-Rodríguez, Martín Morrugares, Rosario Muñoz, Eduardo Calzado, Marco A. Cell Mol Life Sci Review Members of the dual-specificity tyrosine-regulated kinase (DYRKs) subfamily possess a distinctive capacity to phosphorylate tyrosine, serine, and threonine residues. Among the DYRK class II members, DYRK2 is considered a unique protein due to its role in disease. According to the post-transcriptional and post-translational modifications, DYRK2 expression greatly differs among human tissues. Regarding its mechanism of action, this kinase performs direct phosphorylation on its substrates or acts as a priming kinase, enabling subsequent substrate phosphorylation by GSK3β. Moreover, DYRK2 acts as a scaffold for the EDVP E3 ligase complex during the G2/M phase of cell cycle. DYRK2 functions such as cell survival, cell development, cell differentiation, proteasome regulation, and microtubules were studied in complete detail in this review. We have also gathered available information from different bioinformatic resources to show DYRK2 interactome, normal and tumoral tissue expression, and recurrent cancer mutations. Then, here we present an innovative approach to clarify DYRK2 functionality and importance. DYRK2 roles in diseases have been studied in detail, highlighting this kinase as a key protein in cancer development. First, DYRK2 regulation of c-Jun, c-Myc, Rpt3, TERT, and katanin p60 reveals the implication of this kinase in cell-cycle-mediated cancer development. Additionally, depletion of this kinase correlated with reduced apoptosis, with consequences on cancer patient response to chemotherapy. Other functions like cancer stem cell formation and epithelial–mesenchymal transition regulation are also controlled by DYRK2. Furthermore, the pharmacological modulation of this protein by different inhibitors (harmine, curcumine, LDN192960, and ID-8) has enabled to clarify DYRK2 functionality. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00018-020-03556-1) contains supplementary material, which is available to authorized users. Springer International Publishing 2020-05-27 2020 /pmc/articles/PMC7658070/ /pubmed/32462403 http://dx.doi.org/10.1007/s00018-020-03556-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Review Correa-Sáez, Alejandro Jiménez-Izquierdo, Rafael Garrido-Rodríguez, Martín Morrugares, Rosario Muñoz, Eduardo Calzado, Marco A. Updating dual-specificity tyrosine-phosphorylation-regulated kinase 2 (DYRK2): molecular basis, functions and role in diseases |
title | Updating dual-specificity tyrosine-phosphorylation-regulated kinase 2 (DYRK2): molecular basis, functions and role in diseases |
title_full | Updating dual-specificity tyrosine-phosphorylation-regulated kinase 2 (DYRK2): molecular basis, functions and role in diseases |
title_fullStr | Updating dual-specificity tyrosine-phosphorylation-regulated kinase 2 (DYRK2): molecular basis, functions and role in diseases |
title_full_unstemmed | Updating dual-specificity tyrosine-phosphorylation-regulated kinase 2 (DYRK2): molecular basis, functions and role in diseases |
title_short | Updating dual-specificity tyrosine-phosphorylation-regulated kinase 2 (DYRK2): molecular basis, functions and role in diseases |
title_sort | updating dual-specificity tyrosine-phosphorylation-regulated kinase 2 (dyrk2): molecular basis, functions and role in diseases |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658070/ https://www.ncbi.nlm.nih.gov/pubmed/32462403 http://dx.doi.org/10.1007/s00018-020-03556-1 |
work_keys_str_mv | AT correasaezalejandro updatingdualspecificitytyrosinephosphorylationregulatedkinase2dyrk2molecularbasisfunctionsandroleindiseases AT jimenezizquierdorafael updatingdualspecificitytyrosinephosphorylationregulatedkinase2dyrk2molecularbasisfunctionsandroleindiseases AT garridorodriguezmartin updatingdualspecificitytyrosinephosphorylationregulatedkinase2dyrk2molecularbasisfunctionsandroleindiseases AT morrugaresrosario updatingdualspecificitytyrosinephosphorylationregulatedkinase2dyrk2molecularbasisfunctionsandroleindiseases AT munozeduardo updatingdualspecificitytyrosinephosphorylationregulatedkinase2dyrk2molecularbasisfunctionsandroleindiseases AT calzadomarcoa updatingdualspecificitytyrosinephosphorylationregulatedkinase2dyrk2molecularbasisfunctionsandroleindiseases |